
RiVax ® Vaccine Candidate for Ricin Poisoning Treatment - Soligenix
Intended for use with emergency first responders and warfighters that may unexpectedly encounter ricin toxin, RiVax ® is a thermostabilized vaccine candidate which can be stored at room temperature for extended periods, compatible …
RiVax, a recombinant ricin subunit vaccine, protects mice ... - PubMed
Oct 16, 2007 · Our recombinant ricin A chain vaccine (RiVax), which contains mutations in both known toxic sites, has no residual toxicity at doses at least 800 times the immunogenic dose. RiVax without adjuvant given intramuscularly (i.m.) protected mice against intraperitoneally administered ricin.
FDA Grants Soligenix "Fast Track" Designation for RiVax® in …
Feb 13, 2020 · RiVax ® is Soligenix's proprietary heat stable recombinant subunit vaccine developed to protect against exposure to ricin toxin, the threat of which has been highlighted recently in the news with...
Medical Countermeasures against Ricin Intoxication - PMC
Rivax is an alum-adjuvanted subunit vaccine candidate that may prevent death and injury from any route of exposure to RT. A major advantage of this vaccine is that RiVax ® is a thermostabilized vaccine candidate that can be stored at room temperature for extended periods and is stable up to 40 °C.
RiVax, a recombinant ricin subunit vaccine, protects mice against …
Oct 16, 2022 · Ricin is a plant toxin that is a CDC level B biothreat. Our recombinant ricin A chain vaccine (RiVax), which contains mutations in both known toxic sites, has no residual toxicity at doses at least 800 times the immunogenic dose. RiVax without ...
Structure of RiVax: a recombinant ricin vaccine - PubMed
RiVax is a recombinant protein that is currently under clinical development as part of a human vaccine to protect against ricin poisoning. RiVax includes ricin A-chain (RTA) residues 1-267 with two intentional amino-acid substitutions, V76M and Y80A, aimed at reducing toxicity.
Soligenix Demonstrates Extended Protection with its RiVax® …
Dec 8, 2020 · RiVax ® is Soligenix's proprietary heat stable recombinant subunit vaccine developed to protect against exposure to ricin toxin, the threat of which has been highlighted in the news with an envelope addressed to President Trump that was thought to contain this potent and potentially lethal toxin.
Soligenix Demonstrates Extended Protection with RiVax Ricin …
Dec 28, 2020 · Soligenix has demonstrated extended protection with its heat stable ricin toxin vaccine, RiVax®. Mice, vaccinated twice on Days 1 and 21 were protected for at least 365 days against subsequent ricin challenge.
Soligenix Announces Publication Demonstrating Positive …
Dec 20, 2022 · RiVax ® is Soligenix's proprietary heat stable recombinant subunit vaccine developed to protect against exposure to ricin toxin, the threat of which has been highlighted in the...
Intradermal administration of RiVax protects mice from mucosal …
Ricin toxin is a CDC level B biothreat. We have developed a ricin vaccine, RiVax, which is a recombinant mutant of ricin A chain. RiVax is safe, immunogenic and protective in mice when administered intramuscularly (IM).